Euromed’s natural ingredient Pomanox ® shows potential to help reduce food intake
Mollet del Vallès (Spain), September 2022: According to a recently published clinical study by the department of Dietetics, Nutrition and Biological Sciences, those supplementing with Euromed’s natural extract Pomanox ® showed significantly lower levels of hunger and a desire to eat, as well as higher levels of satiety, compared to a placebo group.
In the preliminary, independent, placebo-controlled study conducted at Queen Margaret University, Edinburgh, twenty-eight healthy subjects were given either three-week supplementation with Pomanox® or a placebo. During week three, researchers determined satiety parameters on a testing day after participants ingested breakfast and lunch with pomegranate juice (PJ).
The results suggest that subjects in the Pomanox ® group with the PJ preload were generally more satisfied than those given the placebo. Participants were also less hungry after Pomanox® intake with PJ during the meal than those who consumed placebo juice and capsules.
Scores from the visual analogue scales (VAS), which record subjective sensations, showed significantly lower levels of hunger and a desire to eat, as well as higher levels of fullness and satisfaction, thus greater levels of satiety in participants consuming Pomanox® with PJ, compared to the placebo. These participants also significantly liked the meal’s smell more than the placebo group. Interestingly, the consumption of pomegranate extract was associated with a significantly lower amount of food intake during the satiety session compared with the placebo group.
While preliminary, these findings confirm the appetite-regulating effect of polyphenol-rich extracts reported in previous studies, suggesting novel approaches to reducing risk factors for obesity and compulsive eating and providing more enjoyable meals while dieting.
Andrea Zangara, Scientific Marketing Manager at Euromed, says:
“We are very pleased to see these promising results, as they further support the efficacy and safety of Pomanox ®, expanding its numerous evidence-based health applications to include weight management and behavioural support. Pomanox® is available in different formats and strengths and extracted using safe and eco-friendly, water-only technologies (Pure-Hydro Process®) as with all the other ingredients in our line of Mediterranean Fruit and Vegetable Extracts™. Their production is vertically integrated as they originate from selected fruits grown in the Mediterranean region – close to our dedicated manufacturing plant and in accordance with strict and transparent quality control protocols. In summary, they are ideal for inclusion in premium dietary supplements, functional foods and pharmaceuticals.”
Founded in 1971 by the German pharmaceutical company MADAUS, EUROMED S.A. is a vertically integrated leading producer of standardised botanical extracts and natural active substances for the pharmaceutical, nutraceutical, food and cosmetic industries to support health and well-being with plant-based solutions. Annually, a biomass of more than 5,000 tonnes is extracted at the company’s manufacturing facilities in Mollet del Vallès (Barcelona) and Molina de Segura (Murcia), Spain.
The production plant in Murcia further expands EUROMED’s capabilities with eco-friendly technologies that use a sophisticated water-based extraction method, the Pure-Hydro Process®. All extracts comply with worldwide GMP (Good Manufacturing Practice) norms, international pharmacopoeias and regulations.
EUROMED has a long history of expertise in research and development, laboratory analyses and extraction technologies, and is committed to the highest quality standards in terms of analytics, chemistry and evidence-based therapeutics. This experience is now available to the rapidly expanding global nutraceutical market, which is increasingly seeking pharmaceutical-grade, evidence-based and trusted botanical solutions that support health.